Urinary 11‐dehydrothromboxane B2 concentrations in 20 dogs with primary immune‐mediated hemolytic anemia

Urinary 11‐dehydrothromboxane B2 concentrations in 20 dogs with primary immune‐mediated hemolytic anemia

Abstract Background Thromboembolic disease is a major cause of mortality in dogs with immune‐mediated hemolytic anemia (IMHA). At present, no reliable biomarkers of individual patient thrombotic risk are available. In human medicine, increased urinary thromboxane concentrations have utility as marke...

Full description

Bibliographic Details
Main Authors: Elizabeth A. Conway, Neil P. Evans, Alison E. Ridyard
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Journal of Veterinary Internal Medicine
Subjects:
canine
IMHA
survival
thromboembolism
thromboxane
Online Access:https://doi.org/10.1111/jvim.16322

Internet

https://doi.org/10.1111/jvim.16322

Similar Items